Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis

Urologic Oncology
Italia GrengaJeffrey Schlom

Abstract

Avelumab has recently been approved by the Food and Drug Administration for the therapy of Merkel cell carcinoma and urothelial carcinoma. M7824 is a novel first-in-class bifunctional fusion protein comprising a monoclonal antibody against programmed death-ligand 1 (PD-L1, avelumab), fused to the extracellular domain of human transforming growth factor beta (TGFβ) receptor 2, which functions as a TGFβ "trap." Advanced urothelial tumors have been shown to express TGFβ, which possesses immunosuppressive properties that promote cancer progression and metastasis. The rationale for a combined molecule is to block the PD-1/PD-L1 interaction between tumor cells and immune cell infiltrate and simultaneously reduce or eliminate TGFβ from the tumor microenvironment. In this study, we explored the effect of M7824 on invasive urothelial carcinoma cell lines. Human urothelial (transitional cell) carcinoma cell lines HTB-4, HTB-1, and HTB-5 were treated with M7824, M7824mut (M7824 that is mutated in the anti-PD-L1 portion of the molecule and thus does not bind PD-L1), anti-PD-L1 (avelumab), or IgG1 isotype control monoclonal antibody, and were assessed for gene expression, cell-surface phenotype, and sensitivity to lysis by TRAIL, antigen-sp...Continue Reading

References

Dec 21, 2002·Differentiation; Research in Biological Diversity·Nancy Dumont, Carlos L Arteaga
Jul 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans von der MaaseMichael Arning
Jun 20, 2006·Cancer Immunology, Immunotherapy : CII·Klara BerencsiDorothee Herlyn
Sep 16, 2006·Immunological Reviews·Thomas F GajewskiHelena Harlin
Jan 13, 2012·Current Opinion in Immunology·Suzanne L TopalianDrew M Pardoll
Feb 1, 2013·International Journal of Cancer. Journal International Du Cancer·James W HodgeSofia R Gameiro
Aug 21, 2014·Journal of Immunotoxicology·Fabian Caja, Luca Vannucci
Dec 6, 2014·Cancer Research·Clare Y SlaneyPhillip K Darcy
May 22, 2016·Biochimica Et Biophysica Acta·Ana Cano-González, Abelardo López-Rivas
Jun 9, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christophe MassardNeil H Segal
Jun 21, 2016·The Lancet Oncology·Vicki Brower
Jun 29, 2016·Clinical & Translational Immunology·Italia GrengaJeffrey Schlom
Jul 2, 2016·Journal of Clinical Medicine·Aristidis Moustakas, Carl-Henrik Heldin
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 5, 2017·The Lancet Oncology·Athanasios Kotsakis, Vassilis Georgoulias
Apr 5, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea B ApoloJames L Gulley
May 12, 2017·Drugs·Matthew S FarinaJoaquim Bellmunt
Nov 2, 2017·Oncotarget·Caroline JochemsJeffrey Schlom

❮ Previous
Next ❯

Citations

May 1, 2020·Cytometry. Part B, Clinical Cytometry·Elena MaryamchikMarcela V Maus
Dec 18, 2019·Cells·Joanna BoguslawskaAgnieszka Piekielko-Witkowska
Aug 1, 2020·Frontiers in Cell and Developmental Biology·Adilson Fonseca TeixeiraHong-Jian Zhu
Apr 10, 2019·Journal of Cancer Research and Clinical Oncology·Jiajing CaiRong Xia
Aug 21, 2019·Frontiers in Oncology·Benjamin E Onderdonk, Steven J Chmura
Oct 13, 2019·Cancer Letters·Yuanyuan Jiang, Hanxiang Zhan
Mar 18, 2021·BioMed Research International·Lu TangHeng Mei
Jun 15, 2021·Current Oncology Reports·Danielle M Pastor, Jeffrey Schlom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.